Travoprost Intraocular Implant + iStent Infinite

This trial compares two treatments for reducing eye pressure in people with glaucoma or ocular hypertension (elevated eye pressure that can damage vision). It tests adding a travoprost intraocular implant (a tiny drug-releasing device placed in the eye) to a procedure called iStent Infinite, versus iStent Infinite alone. **You may be eligible if...** - You have been diagnosed with open-angle glaucoma or ocular hypertension - Your eye pressure qualifies for the study based on screening measurements **You may NOT be eligible if...** - Your unmedicated eye pressure exceeds 36 mmHg - You are allergic to travoprost or any components of the implant - You have a severe visual field loss or a large optic nerve cup-to-disc ratio (>0.8) - Your best corrected vision is worse than 20/80 in either eye - You have another eye disease that could interfere with the study Talk to your doctor to see if this trial is right for you.